HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 649-660 of 1,979
Drug study icon
CompletedEUCTR 2004-005010-37

Enhancing cognition in Bipolarity

Official study title

Enhancing cognition in bipolar disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
BipolarityHistorical research recordAges 18+
Countries
United Kingdom
Sponsor
Suffolk Mental Health Partnerships Trust
Drug study icon
CompletedEUCTR 2010-018671-20

A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolarity type 1 (Phas...

Official study title

A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phas...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria
Sponsor
Forest Research Institute Inc., a wholly owned subsidiary of Forest Laboratories, LLC
Drug study icon
CompletedEUCTR 2010-018410-78

A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed with Bipolarity type 1 who Completed Protocol P05691 (formerly 041044) (Phase3B,...

Official study title

A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed with Bipolar 1 Disorder who Completed Protocol P05691 (formerly 041044) (Phase3B,...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria
Sponsor
Schering-Plough Research Institute, a Division of Schering
Drug study icon
CompletedEUCTR 2010-018409-13

A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolarity type 1 Experie...

Official study title

A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolar 1 Disorder Experie...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria
Sponsor
Schering-Plough Research Institute, a Division of Schering
Drug study icon
CompletedEUCTR 2010-023740-32

Pharmacogenomics of Mood Stabilizer Response in Bipolarity

Official study title

Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Norway
BipolarityHistorical research record
Countries
Norway
Sponsor
Haukeland University Hospital [...] 1. Haukeland University Hospital 2.
Drug study icon
Recruitment unclearEUCTR 2008-004746-81

Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
BipolarityHistorical research record
Countries
Netherlands
Sponsor
Parnassia-BAVO groep [...] 1. Parnassia-BAVO groep 2. St. Elisabeth Ziekenhuis 3. University Medical Center Utrecht
Other study type icon
CompletedNCT00888264

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

Official study title

A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode

This study has finished and is no longer accepting participants.

Multiple locations, including Aarschot
BipolarityObservational studyAges 18–65
Countries
Belgium
Sponsor
AstraZeneca
Other study type icon
CompletedNCT02083978

Bipolar Research Study Using MR Imaging

Official study title

Neuromorphometry of Psychosis in Bipolar Disorder

This study has finished and is no longer accepting participants.

In St Louis
BipolarityObservational studyAges 18–30
Countries
United States
Sponsor
Washington University Early Recognition Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.